Brief: Neurobo Pharmaceuticals - Appointed Marshall H. Woodworth As Co’S Acting CFO,
Oct 30 (Reuters) - Neurobo Pharmaceuticals Inc NRBO.O :
* NEUROBO PHARMACEUTICALS - ON OCT 25, APPOINTED MARSHALL H.
WOODWORTH AS CO’S ACTING CFO, PRINCIPAL FINANCIAL OFFICER AND
PRINCIPAL ACCOUNTING OFFICER
Source text for Eikon: ID:
Further company coverage: NRBO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MetaVia
See all newsMetaVia Inc reports results for the quarter ended June 30 - Earnings Summary
MetaVia Q2 net loss widens on higher R&D spending
MetaVia Inc expected to post a loss of 82 cents a share - Earnings Preview
Brief: Biostem Technologies Announces Appointment Of Three New Members To Its Board Of Directors
MetaVia Q1 net loss widens slightly as expenses rise